Taysha Gene Therapies shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Taysha Gene Therapies
Tip: Access up to 7 years of quarterly data
All positions including Taysha Gene Therapies held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Taysha Gene Therapies by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $51k | 16k | 3.27 |
| 2025-06-30 | $36k | 16k | 2.31 |
| 2025-03-31 | $22k | 16k | 1.39 |
| 2024-12-31 | $27k | 16k | 1.73 |
| 2024-09-30 | $32k | 16k | 2.01 |
| 2024-06-30 | $35k | 16k | 2.24 |
| 2022-03-31 | $11k | 1.7k | 6.30 |
| 2021-12-31 | $20k | 1.7k | 11.46 |
| 2021-09-30 | $32k | 1.7k | 18.34 |
| 2021-06-30 | $37k | 1.7k | 21.20 |
| 2021-03-31 | $15k | 727 | 20.63 |
| 2020-12-31 | $19k | 727 | 26.13 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors